TrialAutopsyBuilt by Jawad Momani (Pwnedl0l)

Autopsy report · NCT00805740

An Evaluation Of The Effectiveness And Safety Of Anidulafungin Compared To Caspofungin For The Treatment Of Deep Tissue Infection Due To Candida

Cause of deathFunding or business, also safety Automatic label, confidence 0.5, unverified. How labels are made.
“The study was terminated prematurely on May 18, 2012 due to slow enrollment. The study was not terminated due to any safety issues or concerns.”

The sponsor’s own words in the registry.

Life of this trial

2008200920102011201220132014Registered2008-11-26Started2009-04Stopped2012-06Results posted2013-08-01

Vital statistics

Status
Terminated
Phase
Phase 3
Sponsor
Pfizer
Sponsor type
Industry
Conditions
Candidiasis; Fungemia
Interventions
Active anidulafungin; Active Caspofungin
Participants
41
Sites
18
Countries
Belgium, Bulgaria, Canada, Netherlands, Portugal, Romania, Russia, Switzerland, United States

Trials that died the same way

Look deeper

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.